Stockholders' Deficit (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|---|
Dec. 26, 2018 |
Dec. 31, 2018 |
Dec. 31, 2018 |
Dec. 31, 2019 |
Nov. 26, 2014 |
|
| Number of shares issued, vlaue | $ 3,695,000 | ||||
| Number of common stock shares sold | 335,910 | ||||
| Sale of stock price per share | $ 11.00 | ||||
| Number of common stock shares sold, value | $ 3,695,010 | ||||
| Aggregate intrinsic value of exercisable options | $ 738,000 | ||||
| Unrecognized stock-based compensation expense | $ 1,601,000 | ||||
| Unrecognized stock-based compensation weighted average period | 1 year 6 months 14 days | ||||
| 2014 Equity Incentive Plan [Member] | |||||
| Share based compensation, number of shares authorized | 1,000,000 | ||||
| Cleveland Capital L.P [Member] | |||||
| Proceeds from offering | $ 2,600,000 | ||||
| Investor [Member] | Private Placement [Member] | |||||
| Number of shares issued | 454,546 | ||||
| Number of shares issued, vlaue | $ 5,000,000 | ||||
| Common stock per share | $ 11.00 | $ 11.00 | |||
| Investor [Member] | Private Placement [Member] | Maximum [Member] | |||||
| Number of shares issued, vlaue | $ 7,000,000 |
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cost to be recognized for option under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from entity's first offering of stock to the public. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition Number of shares authorized for issuance under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|